|
Market Analysis Reports of Sumatriptan N-Oxide
|
2020 Cluster Headache Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... gene-related peptide antagonist; Nitric oxide synthase inhibitor; NMDA receptor antagonists ... include- CLE-500, Ketamine hydrochloride, sumatriptan, galcanezumab, MTR-108 (Raviclust), zucapsaicin ...
|
|
|